Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2024.419 | Dysarthric Speech Pattern Detection, Analysis and Reconstruction for Rehabilitation Training |
Prof. MENG Helen Mei Ling 蒙美玲 |
| 2024.418 | An evaluation of the effectiveness and cost-effectiveness of the Chronic Disease Co-Care (CDCC) Pilot Scheme: a commissioned study | Dr. LEUNG Shuk Yun |
| 2024.417 | Assessing Cancer Risk and Comorbidities in Diabetic vs. Non-Diabetic Patients in Hong Kong: a retrospective cohort study | Prof. HUANG Junjie |
| 2024.416 | Independent double-checking of medication in emergency departments of hospitals: A sequential mixed-methods design | Prof. LAU Ying |
| 2024.415 | Independent double-checking of medication in emergency departments of hospitals: A sequential mixed-methods design |
Ms. CHUNG Josephine Yuen Man 鐘婉雯 |
| 2024.414 | Independent double-checking of medication in emergency departments of hospitals: A sequential mixed-methods design |
Ms. SHIU Irene Yuk Chun 蕭玉珍 |
| 2024.413 | Analysis of Time to diagnosis & Outcomes of Primary Hyperparathyroidism in adults in a local hospital | Dr. LAM Long Yi |
| 2024.412 | Comparison of Acute Kidney Injury Risk Prediction Scores after Aortic and Cardiac Surgery | Dr. LEE Christopher P.T. |
| 2024.411 | Effect of feedback devices on chest compression quality in Hong Kong nurses: A cross-over manikin study |
Mr. LEE Wai Yat 李瑋日 |
| 2024.410 | Effects of High-Intensity Interval Training on Physical Fitness, Cognitive and Mental Health in Hong Kong Adolescents with Intellectual Disabilities: A Cluster-Randomized Controlled Trial |
Prof. POON Eric Tsz Chun Eric Tsz-chun Poon |
| 2024.409 | A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy | Prof. YEO Winnie |
| 2024.408 | Preoperative continuous PENG block for geriatric hip fracture patients: a pilot feasibility study | Dr. TENG Irving |
| 2024.407 | Measuring the neural markers of hearing and spatial hearing in normal hearing and hearing impaired using functional near-infrared spectroscopy and electroencephalography | Dr. SCHNUPP Jan |
| 2024.406 | Hong Kong old age home nurses’ attitudes and knowledge toward advance directive | Mr. TSE Tsz Tsun |
| 2024.405 | FOXC1 regulatory network in trastuzumab resistance of HER2+ breast cancer and potential clinical values |
Dr. TSE Gary Man Kit 謝文杰 |
| 2024.404 | Outcome prediction of breast cancer patients with neoadjuvant therapy |
Prof. TSE Gary Man Kit 謝文杰 |
| 2024.403 | Functional characterization of a novel 19q13 KRAB-zinc-finger repressor in regulating cancer stemness and metastasis of esophageal cancer | Prof. TAO Qian |
| 2024.402 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Povetacicept in Adults with Immunoglobulin A Nephropathy (RAINIER) |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2024.401 | Evaluating a novel, allosteric glucokinase activator in monogenic diabetes secondary to inactivating glucokinase mutations: a randomised, cross-over trial | Dr. CHOW Elaine |
| 2024.400 | Emergency Stroke Unit for Acute Cerebrovascular Events: A Prospective, Single-arm Trial with a Historical Control Group | Prof. LEUNG Thomas Wai Hong |
| 2024.399 | Combined Leadless Pacemaker and Left Atrial Appendage Occlusion Registry |
Prof. TAM Tsz Kin 譚子健 |
| 2024.398 | Adjunctive Fludrocortisone in Septic Shock: a multicenter, double-blind, randomized, placebo-controlled pilot trial (AFLUDROS-1) | Dr. LING Lowell |
| 2024.397 | Beamion LUNG-2: A Phase III, open-label, randomized, active-controlled, multi-centre trial evaluating orally administered zongertinib (BI 1810631) compared with standard of care as first-line treatment in patients with unresectable, locally advanced or metastatic non-squamous non-small cell lung cancer harbouring HER2 tyrosine kinase domain mutations | Dr. LOONG Herbert Ho Fung |
| 2024.396 | Integrative machine learning analysis of gut microbiome for predicting conversion from mild cognitive impairment to dementia | Dr. LEE Allen Ting Chun |
| 2024.395 | Non-curative ESDs: Assessing the Rates and Risk Factors for Residual Neoplasia |
Dr. YIP Hon Chi 葉瀚智 |
| 2024.394 | Mycophenolate mofetil in Chinese patients with immune thrombocytopenia | Dr. WONG Raymond |
| 2024.393 | Integrating Novel Artificial Intelligence-Based Privacy-Preserving Technology with Multi-centre Heterogeneous Data for Assessing Eye and Systemic Diseases | Dr. HO Mary |
| 2024.392 | Integration of team-based learning and simulation-based learning in clinical education of infant dysphagia assessment and management of Speech-Language Pathology students: A cross-sectional observational study |
Ms. KWAN Ching Yin 關靜然 |
| 2024.391 | Independent associated factors of long term inappropriate use of Proton Pump Inhibitors in Older Adults | Dr. CHAN Chak Hei |
| 2024.390 | The disease epidemiology and treatment of haemophilia A and B patients in Hong Kong |
Dr. WONG Raymond Siu Ming 王紹明 |
| 2024.389 | Community burden of Mycoplasma genitalium infection and its implications for test-and-treat strategies | Prof. WONG Ngai Sze |
| 2024.388 | Prevalence of Small Vessel Disease in Patients with Cardiovascular Risk Factors - A hospital-based study | Dr. IP Bonaventure Yiu Ming |
| 2024.387 | Using Real-world Big Data to Reveal the Associations between Coexisting Chronic Diseases, Medications, and Cancer | Prof. NG Chi Fai |
| 2024.386 | A Multimodal AI-driven Platform for Precision Risk Assessment of Oral Potentially Malignant Disorders to Improve Prevention and Early Detection of Oral Cancer | Prof. CHAN Jason Ying Kuen |
| 2024.385 | Efficacy of Helmet Therapy for Deformational Plagiocephaly: A Pilot Study | Prof. LAU Adam Yiu Chung |
| 2024.381 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants with Immunoglobulin A Nephropathy (IgAN) |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2024.380 | Genome Study of Myopia Endophenotypes, Development, Progression and Intervention in Chinese Children |
Prof. CHEN Lijia Yan Yu Julia CHAN |
| 2024.379 | Phase 2 Study of Futibatinib 20 mg and 16 mg in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements | Prof. CHAN Stephen Lam |
| 2024.378 | Neurophysiological markers of successful normalization and abstraction in speech learning | Prof. FENG Gangyi |
| 2024.377 | A retrospective cohort study: Impact of a pre-hospital stroke notification on the timeliness of care for hemorrhagic stroke patients in a Hong Kong emergency department. | Mr. WAN Cheuk Kwan |
| 2024.376 | Enhanced laser parameters for Micropulse Transscleral Cyclophotocoagulation (MPCPC) in glaucoma patients: a randomized controlled trial for evaluation of clinical efficacy and cost-effectiveness |
Prof. THAM Clement Chee Yung 譚智勇 |
| 2024.375 | User-Testing Protocol for the Cloud DX Vitaliti Continuous Vital Signs Monitor (Model CVSM-1A) for Clinical Use and Self Measurement in Ambulatory Settings |
Prof. CHAN Matthew Matthew Chan |
| 2024.374 | Functional Assessment for Surgery by a Timed Walk (FAST Walk) |
Prof. CHAN Matthew 陳德威 |
| 2024.373 | Risk of non-arteritic anterior ischemic optic neuropathy with glucagon-like peptide-1 receptor agonist – a territory-wide study | Dr. IP Bonaventure Yiu Ming |
| 2024.372 | Primary Care Community Pharmacy Project: Evaluation of Medication Management Service | Ms. KWAN Florence |
| 2024.371 | A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Compensated Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH) |
Prof. WONG Vincent Wai Sun Vincent Wai Sun Wong |
| 2024.370 | Preserving brain health after surgery: does light general anaesthesia reduce postoperative delirium and cognitive decline compared with deep general anaesthesia in older adults? The Balanced-2 Study |
Dr. CHAN Matthew Matthew Chan |
| 2024.369 | Effects of a linguistically appropriate decision aid for the mammography screening of South Asian women in Hong Kong: A pilot randomised controlled trial | Dr. CHAN Dorothy N.S. |
| 2024.368 | A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-022, an anti-TIM-3 Monoclonal Antibody, in Patients with Advanced Solid Tumors (AMBER) | Prof. CHAN Stephen Lam |
| 2024.367 | Association between SARS-CoV-2 rebound and post-COVID-19 conditions: a retrospective cohort study | Dr. CHONG Ka Chun |
Page 34 of 288.